WallStreetZenWallStreetZen

NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Beth C. SeidenbergDirector2025-12-18133,333$7.50
$1,000.00kBuy
Westlake Biopartners Opportunity Fund I LP10% Owner2025-12-18133,333$7.50
$1,000.00kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$4.83
$115.91kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$12.20
$292.78kSell

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC10.91%4,777,060$38.26MInsider
Fred E. Cohen10.37%4,540,558$36.37MInsider
Vida Ventures Advisors LLC10.33%4,523,924$36.24MInstitution
Gilead Sciences Inc9.42%4,126,119$33.05MInstitution
Gilead Sciences Inc9.42%4,126,119$33.05MInsider
Beth C. Seidenberg8.69%3,804,574$30.47MInsider
Westlake Biopartners Opportunity Fund I LP8.65%3,787,940$30.34MInsider
Bain Capital Life Sciences Investors LLC7.69%3,368,370$26.98MInstitution
Northpond Ventures III GP LLC7.43%3,255,426$26.08MInsider
Bain Capital Life Sciences Investors LLC7.22%3,163,868$25.34MInsider

1 of 3

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX43.64%56.36%Net BuyingNet Buying
PEPG82.51%9.24%Net Buying
AURA81.33%14.84%Net SellingNet Selling
LCTX36.54%63.46%Net SellingNet Selling
AUTL54.35%0.00%
View Top Biotech Stocks

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 51.82% institutional shareholders, 66.93% Kyverna Therapeutics insiders, and 0.00% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 10.91% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $38.26M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.